TirzeBlog
HomesaúdeEfeitos ColateraisAlimentaçãoExercício e Corpo
Get the app

Ozempro — Monitor GLP-1

Get the app and track your treatment

Dose reminders, weight tracking and a symptom diary. Free · iOS and Android.

Build my plan

or download the app

Baixar naApp StoreDISPONÍVEL NOGoogle Play
TirzeBlog

Entenda a Tirzepatida — tips, articles and guides for your wellness journey.

Navigation

  • Home
  • About

Categories

  • saúde
  • Efeitos Colaterais
  • Alimentação
  • Exercício e Corpo
  • Saúde Mental
  • Como Usar
  • Tratamento
© 2026 TirzeBlog. All rights reserved.
PrivacyTerms of UseCookies
  1. Blog
  2. ›Tratamento
  3. ›Survodutide: The Dual GLP-1/Glucagon Agonist That Could Change Obesity Treatment in 2026
Tratamento

Survodutide: The Dual GLP-1/Glucagon Agonist That Could Change Obesity Treatment in 2026

July 19, 2026·5 min read·22 views·Equipe Editorial TirzeBlog
TirzeBlog

Survodutide: The Dual GLP-1/Glucagon Agonist That Could Change Obesity Treatment in 2026 The pharmaceutical industry has brought a series of medications in recent years that changed how weight loss is approached. GLP-1 agonists, like semaglutide, led the way and showed impressive results. Bu.

Survodutide: The Dual GLP-1/Glucagon Agonist That Could Change Obesity Treatment in 2026

The pharmaceutical industry has brought a series of medications in recent years that changed how weight loss is approached. GLP-1 agonists, like semaglutide, led the way and showed impressive results. But now a new drug is catching researchers' attention: survodutide, a dual agonist for GLP-1 and glucagon receptors, developed by Boehringer Ingelheim in collaboration with Zealand Pharma. The data released in 2026 shows numbers that deserve attention.

What survodutide is

While traditional weight loss medications work on a single receptor, survodutide works on two at the same time. It activates both the GLP-1 receptor and the glucagon receptor. Each of those mechanisms brings different benefits to the body. GLP-1, already well-known, helps control appetite, reduces food intake, and improves the body's insulin response. Glucagon, on the other hand, increases energy expenditure and promotes fat burning more directly.

That dual combination is what sets survodutide apart from other available treatments. Instead of relying on a single metabolic pathway, the medication takes advantage of two at the same time, which may translate into more significant and sustained weight loss over time.

The 2026 data

Phase 3 clinical trials presented by Boehringer Ingelheim show encouraging results. In studies with patients who had obesity or overweight, survodutide demonstrated an average weight loss exceeding 20% of body weight after 72 weeks. That figure is above what has been observed with other drugs in the same class.

Beyond weight loss, the studies revealed important improvements in metabolic markers. Many participants showed reduced blood pressure, better cholesterol levels, and more efficient blood sugar control. Those additional benefits are relevant because they show the medication works on overall metabolic health, not just the number on the scale.

The most common side effects were similar to those of other GLP-1 agonists: nausea, vomiting, and some digestive issues, especially at the start of treatment. Those symptoms tend to decrease over time and are generally manageable with dose adjustments.

Missing a dose happens — Ozempro reminds you and keeps your injection history.

Build my plan

How it works in practice

For anyone considering treatment options, understanding the mechanism matters. Survodutide acts on the hypothalamus, the region of the brain responsible for controlling hunger and satiety. By activating those receptors, the medication noticeably reduces the urge to eat and prolongs the feeling of fullness after meals.

At the same time, the increase in energy expenditure from glucagon receptor activation makes the body burn more calories even at rest. That dual action on appetite and metabolism is what makes this approach promising.

It is important to note that this type of medication does not replace adopting healthier habits. The best clinical experience comes when drug treatment is combined with dietary changes and regular physical activity. Medical supervision is essential to adjust doses, monitor results, and ensure the process is safe.

descricao

What it means for the future of obesity treatment

The arrival of medications like survodutide represents a paradigm shift in how obesity is approached. For a long time, treating this chronic condition was limited to lifestyle interventions, with often unsatisfactory results for many patients. Today medicine has tools that work directly on the biological mechanisms that contribute to weight gain.

The development of dual agonists like survodutide also shows how pharmaceutical research is moving toward more precise and personalized treatments. The possibility of combining multiple mechanisms of action in a single medication opens new perspectives for people who did not achieve satisfactory results with other options.

For those closely following health trends, understanding how these medications work is becoming increasingly relevant. Many people still do not know the options that are emerging and how they can help with weight control safely and under guidance.

If you are curious about which treatment approach might be more suitable for your case, there are platforms that help identify possibilities based on your profile. Accessing through here, for example, you can complete a quiz that helps understand which tools might be useful on your journey.

Relying on memory for doses and side effects is risky. Log everything in one place.

Build my plan

Important considerations before starting any treatment

Before considering any weight loss medication, it is fundamental to undergo a complete medical evaluation. Obesity is a complex disease with genetic, metabolic, psychological, and behavioral factors. The most effective treatment generally involves a multidisciplinary approach.

It is also worth noting that each person responds differently to medications. What works well for one person may not be the best option for another. That is why professional follow-up is as important as the medication itself.

Another relevant point is continuity. Significant results with medications like survodutide require time and long-term commitment. It is not a quick fix, but a tool that, when used correctly, can bring meaningful improvements in quality of life.

Outlook for the coming years

Although the data is promising, survodutide may take time to reach the Latin American market. The regulatory approval process and price negotiations can stretch for months or even years. Additionally, the cost of new obesity medications tends to be high, raising questions about access and coverage by health systems.

Meanwhile, staying informed about existing and developing options is a way to prepare for future decisions. Knowledge helps have more productive conversations with health professionals and make more conscious decisions.

The outlook for the coming years looks increasingly promising. With new medications entering the market and research expanding, the trend is that obesity treatment will become more accessible, effective, and personalized. The key is to follow these changes responsibly and seek qualified guidance.

Maintaining a follow-up routine, knowing your own body, and exploring available tools are concrete steps anyone can take. And for those seeking practical guidance on where to start, there are resources that can help identify the best strategies for your situation.

22 views
Share

Disclaimer: This content is for informational purposes only and does not replace professional medical advice. Always consult your doctor before starting, changing or stopping any treatment.

Ozempro — Monitor GLP-1

Never miss a dose and track everything

Injection reminders, a dose history and a side-effects diary — all organized to bring to your appointment.

Build my plan

or download the app

Baixar naApp StoreDISPONÍVEL NOGoogle Play

In this article

Official app

Ozempro

Your daily companion for GLP-1 treatment

  • Dose application reminders
  • Weight and progress chart
  • Side-effects diary
Build my plan

or download the app

Baixar naApp StoreDISPONÍVEL NOGoogle Play

Free · iOS and Android

Related Articles

View all
saúde

MASLD, MASH and GLP-1: What Nobody Tells You About the Revolution in Hepatology

MASLD, MASH and GLP-1: What Nobody Tells You About the Revolution in Hepatology For decades, non-alcoholic fatty liver disease was ignored. Doctors mentioned it as a footnote, something that appeared in test results but did not deserve much attention. Today the situation is completely differ.

July 21, 2026 · 4 min read
GLP-1 Medications and Kidney Health: What the FLOW Trial Taught Us About Protecting Your Kidneys
Tratamento

GLP-1 Medications and Kidney Health: What the FLOW Trial Taught Us About Protecting Your Kidneys

GLP-1 Medications and Kidney Health: What the FLOW Trial Taught Us About Protecting Your Kidneys When doctors started prescribing GLP-1 medications like semaglutide for weight loss and blood sugar control, nobody expected them to become one of the biggest stories in kidney medicine in decades.

July 21, 2026 · 6 min read
Resultado real com GLP-1: o que a ciência diz sobre perda de peso em 6 meses
saúde

Resultado real com GLP-1: o que a ciência diz sobre perda de peso em 6 meses

O que os estudos mostram sobre a perda de peso real com GLP-1 em 6 meses

July 20, 2026 · 6 min read

Ozempro

Free · Dose reminders, weight tracking and a symptom diary.

My plan